C-MER Eye Care Holdings Limited

SEHK:3309 주식 보고서

시가총액: HK$3.5b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

C-MER Eye Care Holdings 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Dennis Lam

최고 경영자

HK$6.0m

총 보상

CEO 급여 비율95.7%
CEO 임기no data
CEO 소유권0.7%
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간5yrs

최근 관리 업데이트

Shareholders Will Probably Hold Off On Increasing C-MER Eye Care Holdings Limited's (HKG:3309) CEO Compensation For The Time Being

May 21
Shareholders Will Probably Hold Off On Increasing C-MER Eye Care Holdings Limited's (HKG:3309) CEO Compensation For The Time Being

Recent updates

Shareholders Will Probably Hold Off On Increasing C-MER Eye Care Holdings Limited's (HKG:3309) CEO Compensation For The Time Being

May 21
Shareholders Will Probably Hold Off On Increasing C-MER Eye Care Holdings Limited's (HKG:3309) CEO Compensation For The Time Being

C-MER Eye Care Holdings' (HKG:3309) Earnings May Just Be The Starting Point

Apr 29
C-MER Eye Care Holdings' (HKG:3309) Earnings May Just Be The Starting Point

C-MER Eye Care Holdings Limited's (HKG:3309) 26% Share Price Plunge Could Signal Some Risk

Feb 02
C-MER Eye Care Holdings Limited's (HKG:3309) 26% Share Price Plunge Could Signal Some Risk

C-MER Eye Care Holdings (HKG:3309) Might Be Having Difficulty Using Its Capital Effectively

Jan 17
C-MER Eye Care Holdings (HKG:3309) Might Be Having Difficulty Using Its Capital Effectively

A Look At The Intrinsic Value Of C-MER Eye Care Holdings Limited (HKG:3309)

Apr 24
A Look At The Intrinsic Value Of C-MER Eye Care Holdings Limited (HKG:3309)

Capital Allocation Trends At C-MER Eye Care Holdings (HKG:3309) Aren't Ideal

Dec 04
Capital Allocation Trends At C-MER Eye Care Holdings (HKG:3309) Aren't Ideal

Is C-MER Eye Care Holdings (HKG:3309) A Risky Investment?

Sep 22
Is C-MER Eye Care Holdings (HKG:3309) A Risky Investment?

Update: C-MER Eye Care Holdings (HKG:3309) Stock Gained 25% In The Last Year

Dec 07
Update: C-MER Eye Care Holdings (HKG:3309) Stock Gained 25% In The Last Year

CEO 보상 분석

Dennis Lam 의 보수는 C-MER Eye Care Holdings 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Dec 31 2023HK$6mHK$6m

HK$62m

Sep 30 2023n/an/a

HK$28m

Jun 30 2023n/an/a

-HK$7m

Mar 31 2023n/an/a

-HK$14m

Dec 31 2022HK$6mHK$6m

-HK$22m

Sep 30 2022n/an/a

HK$545k

Jun 30 2022n/an/a

HK$23m

Mar 31 2022n/an/a

HK$22m

Dec 31 2021HK$6mHK$6m

HK$22m

Sep 30 2021n/an/a

HK$25m

Jun 30 2021n/an/a

HK$28m

Mar 31 2021n/an/a

HK$11m

Dec 31 2020HK$4mHK$4m

-HK$6m

Sep 30 2020n/an/a

-HK$10m

Jun 30 2020n/an/a

-HK$13m

Mar 31 2020n/an/a

HK$14m

Dec 31 2019HK$1mHK$1m

HK$41m

Sep 30 2019n/an/a

HK$53m

Jun 30 2019n/an/a

HK$64m

Mar 31 2019n/an/a

HK$53m

Dec 31 2018HK$1mHK$1m

HK$43m

Sep 30 2018n/an/a

HK$35m

Jun 30 2018n/an/a

HK$27m

Mar 31 2018n/an/a

HK$31m

Dec 31 2017HK$4mHK$3m

HK$40m

보상 대 시장: Dennis 의 총 보상 ($USD 771.01K )은 Hong Kong 시장( $USD 358.97K ).

보상과 수익: Dennis 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.


CEO

Dennis Lam (64 yo)

no data

테뉴어

HK$6,018,000

보상

Dr. Shun Chiu Lam, JP, also known as Dennis, serves as Chairman and Chief Executive Officer of C-MER Eye Care Holdings Limited. Dr. Lam is also a director of certain subsidiaries of the Company. Dr. Lam is...


이사회 구성원

이름위치테뉴어보상소유권
Shun Chiu Lam
Chairman & CEOno dataHK$6.02m0.72%
HK$ 25.4m
Xiaoting Li
Executive Director7yrsHK$3.81m데이터 없음
Yau Wing Lee
Head of Hong Kong Operation & Executive Director7yrsHK$240.00k1.06%
HK$ 37.6m
Chiu Cheung Ma
Independent Non-Executive Director6.5yrsHK$240.00k데이터 없음
Pak-kuen Auyeung
Independent Vice Chairman of the Board3.6yrsHK$759.00k0.024%
HK$ 855.1k
Ke Yin
Independent Non-Executive Directorless than a yearHK$120.00k데이터 없음
Shu Kwan Ip
Independent Non-Executive Director3.6yrsHK$240.00k데이터 없음

5.0yrs

평균 재임 기간

64yo

평균 연령

경험이 풍부한 이사회: 3309 의 이사회경험(평균 재직 기간 5 년)으로 간주됩니다.